drugset / Trial / NCT03747081

Efficacy Comparison of Warfarin Versus Rivaroxaban CVT

NCT03747081

Phase 1/2 Unknown 50 enrolled Isfahan University of Medical Sciences
RandomizedParallel-groupOpen-labelTreatment

Summary

With regard to Cerebral Venous Thrombosis (CVT) importance as a life threatening disease, specific care is necessary, Known anti-coagulants have limitations.Vitamin K antagonists such as Warfarin, require laboratory monitoring and exact administration starting and maintenance dose. although Rivaroxaban(selective and direct Xa factor antagonist ) has no monitoring and no drug interaction. This study aim to focus on efficacy of Warfarin versus Rivaroxaban.

Timeline

Start
2018-09-01
Primary completion
2020-01-01
Completion
2020-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Rivaroxaban Other / unclassified 20 mg
Comparator Warfarin Small molecule